COMBINATION OF ANTI-B7-H3 ANTIBODY-DRUG CONJUGATE AND ATR INHIBITOR OR ATM INHIBITOR
Application
US20260091123A1
Kind: A1
Apr 02, 2026
Assignee
DAIICHI SANKYO COMPANY, LIMITED
Inventors
Len KATSUMATA, Jun HASEGAWA, Chiharu HATTORI
Abstract
In some aspects, an object of the present invention is to provide a pharmaceutical composition and a method of treatment comprising administering a specific anti-B7-H3 antibody-drug conjugate in combination with an ATR inhibitor or an ATM inhibitor. Solution: In some aspects, provided is a pharmaceutical composition and a method of treatment, comprising administering an antibody-drug conjugate, in which a drug-linker represented by the following formula: wherein A represents a connecting position to an anti-B7-H3 antibody, and the anti-B7-H3 antibody are conjugated via a thioether bond, in combination with an ATR inhibitor or an ATM inhibitor.
CPC Classifications
A61K 47/6849
A61K 31/4745
A61K 31/5377
A61K 47/545
A61K 47/65
A61K 47/68037
A61P 35/00
Filing Date
2025-10-09
Application No.
19353836